Compare IMMX & OXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMMX | OXM |
|---|---|---|
| Founded | 2014 | 1942 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 629.3M | 675.3M |
| IPO Year | 2021 | 1994 |
| Metric | IMMX | OXM |
|---|---|---|
| Price | $8.96 | $36.51 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | $19.20 | ★ $38.00 |
| AVG Volume (30 Days) | ★ 1.7M | 449.7K |
| Earning Date | 05-08-2026 | 06-10-2026 |
| Dividend Yield | N/A | ★ 6.80% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.00 |
| Revenue | N/A | ★ $1,477,834,000.00 |
| Revenue This Year | N/A | $2.85 |
| Revenue Next Year | N/A | $2.63 |
| P/E Ratio | ★ N/A | $36.27 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.94 | $30.57 |
| 52 Week High | $11.61 | $51.61 |
| Indicator | IMMX | OXM |
|---|---|---|
| Relative Strength Index (RSI) | 49.91 | 36.27 |
| Support Level | $7.99 | $35.94 |
| Resistance Level | $8.97 | $41.58 |
| Average True Range (ATR) | 0.73 | 2.49 |
| MACD | 0.09 | -0.93 |
| Stochastic Oscillator | 43.31 | 13.15 |
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company's business is organized as: Tommy Bahama, Lilly Pulitzer, Johnny Was and Emerging Brands reportable segments. Geographically, the company operates in United States as well as Internationally.